Voltaflam 50 Mg
Reduces pain and swelling by blocking chemicals in your body that trigger inflammatory responses at the source.
Novartis is a prominent global pharmaceutical company based in Switzerland, researching, developing, and manufacturing a range of health solutions. Their commitment spans various therapeutic categories, focusing on addressing significant medical needs across international healthcare systems. Two of their formulations are currently listed here for patient and professional reference.
Reduces pain and swelling by blocking chemicals in your body that trigger inflammatory responses at the source.
Targets protein kinases involved in tumor blood supply to reduce the rate of cancer cell growth.
Novartis is a major multinational pharmaceutical corporation headquartered in Basel, Switzerland. The company operates through a diversified business model, maintaining significant global operations in both innovative medicines and the development of generic pharmaceuticals. They are recognized worldwide for their focus on specialized therapeutic areas, including oncology, cardiovascular health, and immunology.
As a significant contributor to the global pharmaceutical industry, the company maintains extensive research and manufacturing facilities. They produce a vast array of medications that are distributed throughout the United States, United Kingdom, Australia, and Canada, as well as many other international markets. Their approach integrates large-scale drug development with clinical research to serve patients with chronic and acute conditions.
The products listed on this platform represent a specific segment of the company’s broader therapeutic catalog. Their current inventory includes treatments for pain management and oncology. Specific examples from this collection include Voltaflam 50 Mg, which is used for the management of inflammatory conditions, and Votrient 400 Mg, an oncology medication.
These products reflect the manufacturer’s focus on targeted therapy and symptom management. By producing both specialized oncology agents and commonly utilized anti-inflammatory formulations, the company serves a wide range of patients requiring diverse treatment regimens for their respective health conditions.
The products listed are generic pharmaceutical formulations manufactured by Novartis. Individual products differ in active ingredient, formulation, strength, and intended use. This page is a product catalog — it is not medical advice or an endorsement of specific products. Readers should review individual product labeling and consult a healthcare professional for guidance on which product suits their needs.